Déjà vu
The recent publication in JAMA Psychiatry: Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-Analysis made me feel that I had been here before. Once again, a … Continue reading Déjà vu
Tag: JAMA Psychiatry
REDUCED
The REDUCE Trial is open access and can be read here. I submitted the following response hoping that it would be published by JAMA Psychiatry: Comment on: Internet and Telephone … Continue reading REDUCED
Comments on the REDUCE Trial
The REDUCE Trial is open access and can be read here. The following comments have been published on the associated JAMA web-page and are shared below: I have submitted the … Continue reading Comments on the REDUCE Trial
Industry Payments: psychiatry near the top of the list
This letter was published in the Journal of the American Medical Association [JAMA], 28 March 2024. It can be read in full here. I was particularly interested in the specific … Continue reading Industry Payments: psychiatry near the top of the list
“Good news”
Professor Allen Frances, the author of ‘Saving Normal’ recently shared a ‘Systematic Umbrella Review‘ on antidepressants and adverse outcomes. In doing so, Professor Frances described this as: “Good news: Antidepressants … Continue reading “Good news”
“Reassuring results”
This “systematic umbrella review” by Dragioti et al was published in The Journal of the American Medical Association [JAMA]on the 2 October 2019. The President of the Royal College of … Continue reading “Reassuring results”